BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 14644628)

  • 1. Toxicokinetics of chloral hydrate in ad libitum-fed, dietary-controlled, and calorically restricted male B6C3F1 mice following short-term exposure.
    Seng JE; Agrawal N; Horsley ET; Leakey TI; Scherer EM; Xia S; Allaben WT; Leakey JE
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):281-92. PubMed ID: 14644628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary controlled carcinogenicity study of chloral hydrate in male B6C3F1 mice.
    Leakey JE; Seng JE; Latendresse JR; Hussain N; Allen LJ; Allaben WT
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):266-80. PubMed ID: 14644627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and carcinogenesis study of chloral hydrate (ad libitum and dietary controlled) (CAS no. 302-17-0) in male B6C3F1 mice (gavage study).
    US Department of Health and Human Services National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 Dec; (503):1-218. PubMed ID: 12533745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chloral Hydrate (Cas No. 302-17-0) in B6C3F1 mice (Gavage Studies).
    Natl Toxicol Program Tech Rep Ser; 2002 Feb; (502):1-197. PubMed ID: 11965861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight considerations in the B6C3F1 mouse and the use of dietary control to standardize background tumor incidence in chronic bioassays.
    Leakey JE; Seng JE; Allaben WT
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):237-65. PubMed ID: 14644626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of chloral hydrate in mice and rats after single and multiple doses.
    Beland FA; Schmitt TC; Fullerton NF; Young JF
    J Toxicol Environ Health A; 1998 Jun; 54(3):209-26. PubMed ID: 9643873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
    Abbas RR; Seckel CS; Kidney JK; Fisher JW
    Drug Metab Dispos; 1996 Dec; 24(12):1340-6. PubMed ID: 8971140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Sep; 460():1-414. PubMed ID: 12587016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenicity of chloral hydrate administered in drinking water to the male F344/N rat and male B6C3F1 mouse.
    George MH; Moore T; Kilburn S; Olson GR; DeAngelo AB
    Toxicol Pathol; 2000; 28(4):610-8. PubMed ID: 10930049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical effects of chloral hydrate on male rats following 7-day drinking water exposure.
    Poon R; Nadeau B; Chu I
    J Appl Toxicol; 2000; 20(6):455-61. PubMed ID: 11180267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chloral hydrate: a hypnotic best forgotten?].
    Gauillard J; Cheref S; Vacherontrystram MN; Martin JC
    Encephale; 2002; 28(3 Pt 1):200-4. PubMed ID: 12091779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subchronic toxicity of chloral hydrate on rats: a drinking water study.
    Poon R; Nakai J; Yagminas A; Benoit F; Moir D; Chu I; Valli VE
    J Appl Toxicol; 2002; 22(4):227-36. PubMed ID: 12210539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and metabolism of chloral hydrate in children: identification of dichloroacetate as a metabolite.
    Henderson GN; Yan Z; James MO; Davydova N; Stacpoole PW
    Biochem Biophys Res Commun; 1997 Jun; 235(3):695-8. PubMed ID: 9207222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
    Abbas R; Fisher JW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A species comparison of chloral hydrate metabolism in blood and liver.
    Lipscomb JC; Mahle DA; Brashear WT; Garrett CM
    Biochem Biophys Res Commun; 1996 Oct; 227(2):340-50. PubMed ID: 8878519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of enterohepatic circulation on the pharmacokinetics of chloral hydrate and its metabolites in F344 rats.
    Merdink JL; Stenner RD; Stevens DK; Parker JC; Bull RJ
    J Toxicol Environ Health A; 1999 Jul; 57(5):357-68. PubMed ID: 10405189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relative bioavailability and pharmacokinetics of chloral hydrate and its metabolites].
    Zimmermann T; Wehling M; Schulz HU
    Arzneimittelforschung; 1998 Jan; 48(1):5-12. PubMed ID: 9522024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice.
    Merdink JL; Gonzalez-Leon A; Bull RJ; Schultz IR
    Toxicol Sci; 1998 Sep; 45(1):33-41. PubMed ID: 9848108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.